| Serial Number | 88229099 |
| Word Mark | LIFRENZAL |
| Filing Date | Thursday, December 13, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, August 15, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 14, 2019 |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; vaccine preparations; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in in pediatric, geriatric, emergency, family, and human preventative medicine; Pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease |
| Goods and Services | Medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, scientific research services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific research and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific research and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; providing evaluation testing for pharmaceutical, biopharmaceutical and chemical products, and medical devices featuring testing for safety, toxicity, content, identity, purity, configuration and function for others, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research for use in pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, January 6, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, January 6, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AADi Bioscience, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Pacific Palisades, CA 90272 |
| Party Name | AADi Bioscience, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Pacific Palisades, CA 90272 |
| Event Date | Event Description |
| Monday, August 15, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, August 15, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Saturday, January 15, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, January 14, 2022 | SOU EXTENSION 5 GRANTED |
| Thursday, January 6, 2022 | SOU EXTENSION 5 FILED |
| Friday, January 14, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, January 6, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 9, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 7, 2021 | SOU EXTENSION 4 GRANTED |
| Wednesday, July 7, 2021 | SOU EXTENSION 4 FILED |
| Wednesday, July 7, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 5, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 31, 2020 | SOU EXTENSION 3 GRANTED |
| Thursday, December 31, 2020 | SOU EXTENSION 3 FILED |
| Thursday, December 31, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 28, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, July 28, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 28, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, July 9, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 7, 2020 | SOU EXTENSION 2 GRANTED |
| Tuesday, July 7, 2020 | SOU EXTENSION 2 FILED |
| Tuesday, July 7, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 7, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, January 3, 2020 | SOU EXTENSION 1 GRANTED |
| Friday, January 3, 2020 | SOU EXTENSION 1 FILED |
| Friday, January 3, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 9, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 14, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 14, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 24, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, April 8, 2019 | ASSIGNED TO LIE |
| Monday, March 18, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 15, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Friday, March 15, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, March 15, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Friday, March 15, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 11, 2019 | ASSIGNED TO EXAMINER |
| Sunday, January 6, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 17, 2018 | NEW APPLICATION ENTERED |